Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7261 p165
9 August 2003

This article
Reprint
Photocopy


News summary

Related websites
Scottish Pharmaceutical General Council (www.spgc.org.uk)
Scottish Executive (more)


Details of the proposed new pharmacy contract for Scotland are revealed

Basic details of the new contract for community pharmacy in Scotland were outlined last week.

Agreed principles

The Scottish Executive Health Department and the Scottish Pharmaceutical General Council have agreed a number of principles for the new community pharmacy contract. These include:

• Services will be provided that deliver pharmaceutical care efficiently and effectively
• A rational network of pharmacies/pharmacists that provides equitable and convenient access for patients will be supported
• Quality pharmaceutical care services will be properly resourced
• Opportunities for continuing professional development will be provided
• Premises will be fit for their purpose
• A suitable infrastructure will be put in place, including provision of information technology
• Financial turbulence for contractors will be minimised

In a joint letter sent to pharmacists on 31 July, the Scottish Executive Health Department and the Scottish Pharmaceutical General Council describe the progress to date. “The discussions are progressing well with agreement having been reached on the principles to underpin the new contract and on the service elements that the contract is expected to contain,” it says.

Services will be divided into core and additional sections. Core services will be provided by all community pharmacies. They are:

• A chronic medication service that will be based on repeat dispensing and pilot pharmaceutical care schemes in Scotland
• A minor ailments service, similar to the model piloted in Ayrshire and Tayside (see PJ, 23 February 2002, p238)
• A public health service
• An acute medication service — dispensing medicines for acute illness

Additional services will not necessarily be provided by every community pharmacy but instead by some contractors, perhaps acting together within a particular area. The additional services include extended hours provision, out-of-hours services, domiciliary oxygen, harm reduction services and advisory services to care homes. It is expected that a national framework and benchmark tariff will be agreed for these additional services.

There are two main differences between the proposed new contracts in Scotland and England, according to Frank Owens, chairman of the SPGC. First, a minor ailments service will be provided by all community pharmacies in Scotland. In England it seems more likely that this will be classified as an additional service (PJ, 19 July, p77). The second difference is that although services will be divided into core and additional in Scotland, the aim is to avoid a two-tiered approach. He stresses that the services falling into the additional category are those that do not need to be offered by every pharmacy and as such their provision can be agreed locally.

A framework setting out details of the services and the care standards expected is being developed. It is not until this work has been completed that discussions about remuneration will begin. However, the Scottish Executive has said that the new contract will not result in a detrimental effect on the global sum for pharmacy. Full implementation of the new contract is expected in 2005–06 but some phased introduction might begin next year.

Frank Owens offers pharmacists the following reassurance: “My personal view is that there will be no big bang associated with the introduction of the Scottish pharmacy contract,” he told The Journal. “What we are seeking to do is to break down the contract into manageable, bite-size chunks and to phase in the necessary changes. That way we manage the change process better, minimising both financial and operational risk.”

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal